In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pharmacopeia withdraws from merger with Eos

Executive Summary

In a tax-free stock swap, Pharmacopeia (technologies to enhance the drug discovery and chemical development processes) will acquire Eos Biotechnology (genomics-based drug discovery technology) for 10mm common shares plus warrants to buy an additional 600k Pharmacopeia shares valued at $17.07 apiece. There are collar provisions if the share price is below $14.89 at the close of the transaction.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies